Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study
Data on use of monoclonal antibodies (mAbs) in hospitalized patients are limited. In this cross-sectional study, we evaluated the use of mAbs for early treatment of unvaccinated hospitalized patients with mild-to-moderate COVID-19. All inpatients at our center were screened on 27 October 2021. Prima...
Saved in:
Main Authors: | Sean W. X. Ong (Author), Dongdong Ren (Author), Pei Hua Lee (Author), Stephanie Sutjipto (Author), Christopher Dugan (Author), Bo Yan Khoo (Author), Jun Xin Tay (Author), Shawn Vasoo (Author), Barnaby E. Young (Author), David C. Lye (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real world effectiveness of sotrovimab in preventing COVID-19-related hospitalisation or death in patients infected with Omicron BA.2
by: Alwaleed Behzad, et al.
Published: (2024) -
Regional blocks for pre-emptive anti-emesis
by: Deepak Gupta
Published: (2012) -
Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life
by: Luca Cegolon, et al.
Published: (2023) -
Pre-emptive diagnosis of a case of scabies by dermatopathology
by: Cliff Rosendahl, et al.
Published: (2012) -
Pre-emptive Evaluation of Venom Allergy in a Patient with Systemic Mastocytosis
by: Theo Gülen, et al.
Published: (2017)